1887

Abstract

SUMMARY

Two new monoclonal antibodies (MAbs) derived from mice immunized with the Pitman-Moore (PM) strain of rabies virus were used to identify and characterize two unique antigenic determinants on the rabies virus glycoprotein. One of the determinants, which defined an additional antigenic site on the rabies virus glycoprotein, was delineated as a distinct epitope by the newly generated MAb, 6-15C4, in competitive binding studies and by comparative antigenic analysis of neutralization-resistant variant viruses. Both antigenic determinants were compared with the five previously described antigenic sites which bind virus-neutralizing antibodies on the challenge virus standard (CVS) and Evelyn-Rokitnicki-Abelseth (ERA) strain glycoproteins. The results presented in this communication show that the 6-15C4 epitope is the first epitope described in the rabies virus glycoprotein that does not depend on the native conformation of the glycoprotein for binding virus-neutralizing antibody. These data suggest that it may be possible to generate a synthetic peptide vaccine against rabies.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-70-2-291
1989-02-01
2022-01-20
Loading full text...

Full text loading...

/deliver/fulltext/jgv/70/2/JV0700020291.html?itemId=/content/journal/jgv/10.1099/0022-1317-70-2-291&mimeType=html&fmt=ahah

References

  1. Bos E. S., Van Der doelen A. A., Van Rooij M., Schuurs A. H. W. M. 1981; 3,3′,5,5′-Tetramethyl-benzidine as an Ames test negative chromogen for horseradish peroxidase in enzyme immunoassay. Journal of Immunoassay 2:187–204
    [Google Scholar]
  2. Cox J. H., Dietzschold B., Schneider L. G. 1977; Rabies virus glycoprotein. II. Biological and serological characterization. Infection and Immunity 16:754–759
    [Google Scholar]
  3. Dietzschold B., Wiktor T. J., Macfarlan R., Varrichio A. 1982; Antigenic structure of rabies virus glycoprotein: ordering and immunological characterization of the large CNBr cleavage fragments. Journal of Virology 44:595–602
    [Google Scholar]
  4. Dietzschold B., Wiktor T. J., Wunner W. H., Varrichio A. 1983; Chemical and immunological analysis of the rabies virus soluble glycoprotein. Virology 14:330–337
    [Google Scholar]
  5. Dietzschold B., Lafon M., Wang H., Otvos L. JR, Celis E., Wunner W. H., Koprowski H. 1987a; Localization and immunological characterization of antigenic domains of the rabies virus internal N and NS proteins. Virus Research 8:103–125
    [Google Scholar]
  6. Dietzschold B., Tollis M., Rupprecht C. E., celis E., Koprowski H. 1987b; Antigenic variation in rabies and rabies-related viruses. Cross-protection independent of glycoprotein-mediated virus-neutralizing antibody. Journal of Infectious Diseases 156:815–822
    [Google Scholar]
  7. Flamand A., Wiktor T.J., Koprowski H. 1980; Use of hybridoma monoclonal antibodies in the detection of antigenic differences between rabies and rabies-related virus proteins. II. The glycoprotein. Journal of General Virology 48:105–109
    [Google Scholar]
  8. Kearney J. F., Radbruch A., Liesegang B., Rajewsky K. 1979; A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. Journal of Immunology 123:1548–1550
    [Google Scholar]
  9. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, London 227:680–685
    [Google Scholar]
  10. Lafon M., Wiktor T.J., Macfarlan R. I. 1983; Antigenic sites on the CVS rabies virus glycoprotein. Analysis with monoclonal antibodies. Journal of General Virology 64:843–851
    [Google Scholar]
  11. Lafon M., Ideler I., Wunner W.H. 1984; Investigation of the antigenic structure of rabies virus glycoprotein by monoclonal antibodies. Developments in Biological Standardization 57:219–225
    [Google Scholar]
  12. Macfarlan R. I., Dietzschold B., Wiktor T. J., Kiel M., Houghten R., Lerner R. A., Sutcliffe I. G., Koprowski H. 1984; T cell responses to cleaved rabies virus glycoprotein and to synthetic peptides. Journal of Immunology 133:2748–2752
    [Google Scholar]
  13. Nakane P. K., Kawaoi A. 1974; Peroxidase-labeled antibody. A new method of conjugation. Journal of Histochemistry and Cytochemistry 22:1084–1091
    [Google Scholar]
  14. Osterhaus A. D. M. E., Van Wezel A. L., Van Steenis G., Hazendonk A. G., Drost G. A. 1982; Production and potential use of monoclonal antibodies against polioviruses. Developments in Biological Standardization 50:221–223
    [Google Scholar]
  15. Towbin H., Staehelin T., Gordon J. 1979; Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proceedings of the National Academy of SciencesU.S.A. 76:4350–4354
    [Google Scholar]
  16. Turner G. C. 1985; Immune response after rabies vaccination. Basic aspects. Annales de l’Institut Pasteur/Virologie 136E:453–160
    [Google Scholar]
  17. Van Wezel A. L., Van Steenis g., Hannik C. A., Cohen H. 1978; New approaches to the production of concentrated and purified inactivated polio and rabies tissue culture vaccines. Developments in Biological Standardization 41:159–168
    [Google Scholar]
  18. Wiktor T.J., Koprowski H. 1978; Monoclonal antibodies against rabies virus produced by somatic cellhybridization: detection of antigenic variants. Proceedings of the National Academy of SciencesU.S.A. 75:3938–3942
    [Google Scholar]
  19. Wiktor T. J., Koprowski H. 1980; Antigenic variants of rabies virus. Journal of Experimental Medicine 152:99–112
    [Google Scholar]
  20. Wiktor T. J., Gyorgy E., Schlumberger H.D., Sokol F., Koprowski H. 1973; Antigenic properties of rabies virus components. Journal of Immunology 110:269–276
    [Google Scholar]
  21. Wiktor T. J., Kamo I., Koprowski H. 1974; In vitro stimulation of rabbit lymphocytes after immunization with live and inactivated rabies vaccines. Journal of Immunology 112:2013–2019
    [Google Scholar]
  22. Wiktor T. J., Doherty P. C., Koprowski H. 1977; In vitro evidence of cell mediated immunity after exposure of mice to both live and inactivated rabies virus. Proceedings of the National Academy of SciencesU.S.A. 74:334–338
    [Google Scholar]
  23. Wiktor T. J., Macfarlan R. I., Reagan K., Dietzschold B., Curtis P., Wunner W. H., Kieny M. P., Lathe R., Lecocq I. P., Mackett M., Moss B., Koprowski H. 1984; Protection from rabies by vaccinia virus recombinant containing the rabies virus glycoprotein gene. Proceedings of the National Academy of SciencesU.S.A. 81:7194–7198
    [Google Scholar]
  24. Wunner W. H., Dietzschold B., Macfarlan R. I., Smith C. L., Golub E., Wiktor T. J. 1985; Localization of immunogenic domains on the rabies virus glycoprotein. Annales de l’Institut Pasteurj Virologie 136E:353–362
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-70-2-291
Loading
/content/journal/jgv/10.1099/0022-1317-70-2-291
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error